TABLE 2.
Sample No. | Viral copy number (/μL) | Histology | Inflammation grade a | Vacuolation score | ISH b | PCNA | Survivin | Phospho histone‐H3 | Caspase‐3 | TUNEL | |
---|---|---|---|---|---|---|---|---|---|---|---|
Portal area | Parenchymal area | ||||||||||
1 | 4.33 × 103 | HNL | 0 | 0 | 2 | Rare | − | + | − | + | + |
2 | 1.74 × 108 | HPD; C, I | 3 | 6 | 3 | Widespread | +++ | +++ | ++ | − | − |
3 | 4.35 × 106 | HPD; C, I | 2 | 4 | 2 | Widespread | ++ | +++ | + | − | − |
4 | 2.38 × 104 | HPD; A | 1 | 1 | 1 | Rare | + | − | + | − | − |
5 | 1.65 × 102 | HNL | 0 | 0 | 3 | No signals | − | − | − | + | + |
6 | 4.35 × 104 | HPD; A | 1 | 1 | 2 | Rare | + | − | − | − | − |
7 | 1.05 × 105 | HPD; C | 1 | 1 | 0 | Common | + | ++ | + | − | − |
8 | 1.22 × 105 | HPD; C | 1 | 3 | 5 | Common | + | + | − | − | − |
9 | 2.65 × 109 | HPD; C, I | 3 | 6 | 4 | Widespread | +++ | +++ | ++ | − | − |
10 | 1.33 × 105 | HPD; C, I | 3 | 6 | 2 | Widespread | +++ | +++ | ++ | − | − |
11 | 2.65 × 104 | HPD; C | 2 | 4 | 5 | Common | ++ | +++ | ++ | − | − |
Abbreviations: Averaged positive immunoreactivity of proliferative/apoptotic indices: −, no immunoreactivity; +, ≤25% positive immunoreactivity; ++, 26%‐50% positive immunoreactivity; +++, ≥50% positive immunoreactivity. A, acute hepatitis; C, chronic hepatitis; HNL, histologically normal liver; HPD, histological parenchymal disorder; I, interface hepatitis; ISH, in situ hybridization; PCNA, proliferating cell nuclear antigen; TUNEL, terminal deoxynucleotidyl transferase dUTP nick end labeling.
Significant association between viral copy number and histological grading of portal inflammation (P = .014) and parenchymal inflammation (P = .03).
Significant correlation between viral copy number and intensity of staining pattern (P = .004).